LRP3
Low-density lipoprotein receptor-related protein 3
Also known as: hLRp105, LRP-3, LRP3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75074
- Gene
- LRP3
- Ensembl
- ENSG00000130881
- Chromosome
- 19
- Canonical length
- 770 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Lipid droplets
OverviewNCBI Gene
Involved in negative regulation of fat cell differentiation; positive regulation of osteoblast differentiation; and regulation of gene expression. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
770 residues, UniProt reviewed canonical sequence.
>O75074|LRP3
1 MEKRAAAGLE GAPGARAQLA VVCLVNIFLT GRLSSAVPAL AACSGKLEQH TERRGVIYSP
61 AWPLNYPPGT NCSWYIQGDR GDMITISFRN FDVEESHQCS LDWLLLGPAA PPRQEAFRLC
121 GSAIPPAFIS ARDHVWIFFH SDASSSGQAQ GFRLSYIRGK LGQASCQADE FRCDNGKCLP
181 GPWQCNTVDE CGDGSDEGNC SAPASEPPGS LCPGGTFPCS GARSTRCLPV ERRCDGLQDC
241 GDGSDEAGCP DLACGRRLGS FYGSFASPDL FGAARGPSDL HCTWLVDTQD SRRVLLQLEL
301 RLGYDDYVQV YEGLGERGDR LLQTLSYRSN HRPVSLEAAQ GRLTVAYHAR ARSAGHGFNA
361 TYQVKGYCLP WEQPCGSSSD SDGGSLGDQG CFSEPQRCDG WWHCASGRDE QGCPACPPDQ
421 YPCEGGSGLC YTPADRCNNQ KSCPDGADEK NCFSCQPGTF HCGTNLCIFE TWRCDGQEDC
481 QDGSDEHGCL AAVPRKVITA ALIGSLVCGL LLVIALGCAF KLYSLRTQEY RAFETQMTRL
541 EAEFVRREAP PSYGQLIAQG LIPPVEDFPV YSASQASVLQ NLRTAMRRQM RRHASRRGPS
601 RRRLGRLWNR LFHRPRAPRG QIPLLTAARP SQTVLGDGFL QPAPGAAPDP PAPLMDTGST
661 RAAGDRPPSA PGRAPEVGPS GPPLPSGLRD PECRPVDKDR KVCREPLVDG PAPADAPREP
721 CSAQDPHPQV STASSTLGPH SPEPLGVCRN PPPPCSPMLE ASDDEALLVCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 77 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 77 nTPM
- hippocampal formation: 76 nTPM
- cerebral cortex: 74 nTPM
- amygdala: 71 nTPM
- ovary: 62 nTPM
- cerebellum: 40 nTPM
Single-cell type
- retinal ganglion cells: 39 nCPM
- brain inhibitory neurons: 31 nCPM
- brain excitatory neurons: 29 nCPM
- oligodendrocyte progenitor cells: 27 nCPM
- other brain neurons: 27 nCPM
- retinal amacrine cells: 25 nCPM
Immune cell
- non-classical monocyte: 0.6 nTPM
- classical monocyte: 0.5 nTPM
- intermediate monocyte: 0.2 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
Brain region
- cerebral cortex: 146 nTPM
- hippocampal formation: 132 nTPM
- basal ganglia: 118 nTPM
- amygdala: 114 nTPM
- thalamus: 89 nTPM
- midbrain: 77 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.77
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.41
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of fat cell differentiation
- negative regulation of gene expression
- positive regulation of gene expression
- positive regulation of osteoblast differentiation
- receptor-mediated endocytosis
- transport across blood-brain barrier
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRP3 as an antibody target. Whether an autoantibody or antibody against LRP3 could matter depends on whether native LRP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRP3 is annotated at the cell surface, where native LRP3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LRP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...